Options explorer
Explore what may come up in conversation.
This prototype uses melanoma-only source-derived rules. It does not recommend treatment or rank choices.
Options commonly discussed, not recommendations.
This explorer uses structured source-derived prompts. It does not know your full medical history and cannot tell you what treatment to choose.
immunotherapy
Immune checkpoint inhibitor discussion
NCI PDQ lists immunotherapy as a systemic treatment category used in melanoma care. Whether it fits depends on stage, resectability, prior treatment, age, health, and oncology-team judgment.
Questions to ask
- Is immunotherapy being considered before surgery, after surgery, or for metastatic disease?
- What side effects should we watch for early?
- What would make you switch treatments?
clinical-trial
Clinical trial discussion for NRAS-mutant melanoma
NRAS-mutant melanoma often raises questions about limited targeted therapy options and whether a clinical trial is worth discussing. This is a prompt to search and ask, not a claim that any trial fits.
Questions to ask
- Are there NRAS-specific trials we should search for?
- Should we look for trials at a melanoma specialty center?
- What prior treatments would affect whether a trial fits?